Current Report Filing (8-k)
20 8월 2014 - 7:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): August 19, 2014
(Exact Name of Registrant as Specified
in its Charter)
Nevada |
|
000-54770 |
|
45-0704149 |
(State or Other
Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2544 Tarpley Road Suite 12, Carrollton, TX 75006 |
(Address of Principal Executive Office) (Zip Code) |
Registrant's telephone number, including
area code: 214-666-8364
SW CHINA IMPORTS, INC.
12655 North Central Expressway
Suite 100, Dallas TX 75243
(former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2 below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 Other Events.
On August 19, 2014, Med-Cannabis Pharma, Inc. (the
“Company”) announced that the opening of two additional medical marijuana facilities in Washington. One
is located in Hood Canal, Washington, in leased premises consisting of approximately 1,200 with a one year lease term and a
five year renewal option. It opened on August 18, 2014. The second facility will open in Port Townsend, Washington, also in
a 1,200 sq. ft. facility with a two year lease term and a three year renewal option. It will open on August 20, 2014.
SIGNATURES
Pursuant to the requirements of
the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned
hereunto duly authorized.
August 19, 2014 |
MED-CANNABIS PHARMA, INC. |
|
|
|
/s/ Graciela Moreno |
|
|
|
Graciela Moreno, CEO |
|
|
Pegasus Companies (CE) (USOTC:PEGX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Pegasus Companies (CE) (USOTC:PEGX)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024